Tag Archives: IQVIA

Analysts’ View: Amedisys (AMED), IQVIA (IQV), Vishay (VSH)

Brokerage Firm BofA/Merrill upgraded Amedisys, Inc. (NASDAQ:AMED) shares from Neutral to Buy rating while increasing their price target from $88 to $97.

Amedisys, Inc., together with its subsidiaries, provides healthcare services in the United States.


Investment Analysts at Raymond James upgraded IQVIA Holdings Inc. (NYSE:IQV) shares from Outperform to Strong Buy rating.

IQVIA Holdings Inc. provides integrated information and technology-enabled healthcare services in the Americas, Europe, Africa, and the Asia-Pacific.


Vishay Intertechnology, Inc. (NYSE:VSH) shares were upgraded by analysts at Citigroup from Sell to Buy rating.

Vishay Intertechnology, Inc. manufactures and supplies discrete semiconductors and passive components in the United States, Europe, and Asia.


Disclaimer: The disclaimer is to be read and fully understood before using our site, or joining our email list. CRWE.Info is not a registered investment adviser. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Investors should always conduct their own due diligence with any potential investment, with independent research and other professional advice. Read full disclaimer at http://www.crwe.info/disclaimer/